Welcome to our dedicated page for Butterfly Network SEC filings (Ticker: BFLY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Butterfly Network, Inc. filings document the formal disclosures of a public digital health company built around Ultrasound-on-Chip devices, ultrasound software and AI. Recent 8-K reports furnish quarterly and annual results, business updates, material agreements, executive and director matters, and listing-status notices affecting securities issued in connection with its prior business combination with Longview Acquisition Corp.
Proxy materials describe annual meeting proposals, director elections, auditor ratification and executive-compensation votes. Other filings cover the company’s Class A common stock, public warrants, capital structure and governance, including the NYSE Form 25 record for removal of the warrants from listing and registration, while operating disclosures address point-of-care ultrasound and Butterfly Embedded licensing activity.
Butterfly Network insider plans additional stock sale under Rule 144. A holder of Butterfly Network common stock filed to sell 132,570 shares through broker Jefferies on the NYSE, with an aggregate market value of $408,196.00 as of the notice. The shares were originally acquired on 08/31/2014 in a private purchase from Butterfly Network Inc. paid in cash. Over the past three months, the same seller, Dr. Jonathan Rothberg, has already sold multiple blocks of Butterfly Network common stock, including 100,502 shares on 11/03/2025 for gross proceeds of $309,361.24, 1,110,579 shares on 11/24/2025 for $3,503,032.70, 674,758 shares on 11/25/2025 for $2,206,728.56, and 442,539 shares on 11/26/2025 for $1,383,598.00, as disclosed in the notice.
Butterfly Network, Inc. director and 10% owner Jonathan M. Rothberg, Ph.D., reported multiple sales of Class A common stock executed indirectly through family-related LLC trusts. On 11/24/2025 and 11/25/2025, entities EJR TR, LLC, JNR TR, LLC and GBR TR, LLC each sold 370,193 and then about 224,9xx Class A shares at weighted average prices of about $3.15 and $3.27 per share under transaction code “S.” On 11/26/2025, NVR TR, LLC sold 442,539 Class A shares at a weighted average price of about $3.13 per share. The filing states these trades were made under a Rule 10b5‑1 trading plan adopted on March 5, 2025 for estate planning purposes, and that Dr. Rothberg disclaims beneficial ownership of the securities held by the various entities except to the extent of his pecuniary interest.
Butterfly Network (BFLY) insider Dr. Jonathan Rothberg filed a notice to sell 674,758 common shares through broker Jefferies LLC on the NYSE, with an indicated aggregate market value of $2,206,728.56. The filing notes that 226,200,000 common shares were outstanding at the time of the notice.
The shares to be sold were originally acquired on 08/31/2014 via a private purchase from Butterfly Network Inc. for cash. Over the prior three months, Dr. Rothberg sold additional Butterfly Network shares in two transactions: 100,502 shares on 11/03/2025 for gross proceeds of $309,361.24, and 1,110,579 shares on 11/24/2025 for gross proceeds of $3,503,032.70. The signer represents that they are not aware of undisclosed material adverse information about the company.
Butterfly Network (BFLY) reported that shareholder Jonathan Rothberg plans to sell up to 1,110,579 shares of common stock through Jefferies on the NYSE, with an aggregate market value of $3,502,988. The notice lists 226,200,000 common shares outstanding for the company.
The shares planned for sale were originally acquired on 08/31/2014 in a private cash purchase from Butterfly Network Inc. The filing also notes that during the past three months, Rothberg sold 100,502 Butterfly Network shares on 11/03/2025 for gross proceeds of $309,366. The signer represents that they do not know of undisclosed material adverse information about the issuer’s operations.
Butterfly Network, Inc. (BFLY) received an updated Schedule 13D/A (Amendment No. 6) from Glenview Capital and its founder Larry Robbins reporting their current ownership in the company’s Class A common stock.
Glenview Capital Management, LLC reports beneficial ownership of 14,468,477 shares, representing 6.35% of the class, with all voting and dispositive power shared. This includes 12,755,144 shares held by Glenview funds and 1,713,333 shares issuable upon exercise of private placement warrants. Larry Robbins reports beneficial ownership of 22,434,914 shares, or 9.71% of the class, consisting of shared holdings through Glenview and Longview entities plus options and restricted stock units granted in his role on the board. The Glenview funds used approximately $6,793,859.99 of working capital, including commissions, to acquire the shares described in this amendment.
Butterfly Network (BFLY) director Larry Robbins, through Glenview-managed funds, reported open-market purchases of Butterfly Network Class A common stock over three consecutive days. On November 19, 2025, Glenview Investment Funds purchased 1,000,000 shares at a weighted average price of $2.3539 per share. On November 20, 2025, they bought another 1,000,000 shares at a weighted average price of $2.366, followed by 800,000 shares on November 21, 2025 at a weighted average price of $2.5802. After these transactions, Robbins reported 12,755,144 shares beneficially owned indirectly through Glenview funds, 4,546,687 shares indirectly through Longview Investors LLC, and 365,505 shares held directly, which include 80,434 unvested restricted stock units that vest at the company’s 2026 annual stockholders meeting if he continues serving on the board.
Butterfly Network, Inc. (BFLY) entered into a five-year Co-Development and Licensing Agreement with Midjourney, Inc. through its subsidiary BFLY Operations, Inc. The deal gives Midjourney an exclusive, non-transferable license in a defined field to use Butterfly’s semiconductor-based ultrasound-on-chip technology, related software, and backend systems. Butterfly will receive a one-time non-recurring fee of $15 million plus a $10 million annual license fee, payable quarterly during the term.
The Agreement also allows Butterfly to earn up to $9 million in additional milestone payments, revenue-sharing tied to Midjourney’s commercialization of hardware using Butterfly chips, and payments on any chip purchases. The contract includes customary confidentiality and intellectual property provisions, early termination rights for certain breaches or insolvency events, and an option for Midjourney to upgrade its license in specified circumstances.
Butterfly Network (BFLY) reported an insider transaction by Jonathan M. Rothberg, Ph.D., a Director and 10% owner. On 11/03/2025, he sold 100,502 shares of Class A common stock at a weighted average price of $3.078, with sale prices ranging from $3.07 to $3.095. The trade was made under a Rule 10b5-1 trading plan adopted on March 5, 2025.
Following the transaction, 1,140,007 Class A shares were beneficially owned indirectly through EJR TR, LLC. Additional holdings are reported across several entities, and Dr. Rothberg disclaims beneficial ownership except to the extent of his pecuniary interest.
Butterfly Network (BFLY) reported an insider stock transaction on a Form 4. A director sold 112,009 shares of Class A common stock on 11/04/2025 at a weighted average price of $2.695, with individual trades executed between $2.68 and $2.731 per share. The filing states the sale was made to cover tax obligations related to a prior vesting of restricted stock units.
Following the transaction, the reporting person directly holds 265,505 shares. This filing reflects routine tax withholding activity tied to equity compensation rather than an open‑market discretionary sale.
Form 144 filing: A shareholder filed notice to sell up to 100,000 shares of the issuer’s Class A stock through Fidelity Brokerage Services on the NYSE. The filing lists an aggregate market value of $269,139.59 and an approximate sale date of 11/04/2025.
The shares to be sold were acquired via restricted stock vesting from the issuer as compensation, including 48,231 shares on 06/15/2023 and 51,769 shares on 06/12/2025. The filing also notes 226,175,175 shares outstanding. Form 144 is a notice of a potential sale by an affiliate or holder of restricted securities and does not guarantee that any sale will occur.